Nanobiotix (NBTX) Long-Term Investments (2018 - 2025)
Nanobiotix (NBTX) posted Long-Term Investments of $505194.9 for Q4 2025, up 16.44% on a QoQ basis from $433849.7 in Q4 2024, and up 16.44% year-over-year from $433849.7 in Q4 2024.
Nanobiotix (NBTX) has 8 years of Long-Term Investments data on file, last reported at $505194.9 in Q4 2025.
- In Q4 2025, Long-Term Investments rose 16.44% year-over-year to $505194.9; the TTM figure through Dec 2025 stood at $505194.9 (up 16.44% YoY), while the FY2025 annual figure was $490338.1, up 11.59% from the prior year.
- Long-Term Investments advanced to $505194.9 in Q4 2025, from $433849.7 in the prior quarter.
- Across five years, Long-Term Investments topped out at $593720.9 in Q4 2021 and bottomed at $296892.0 in Q4 2022.
- A 5-year average of $430272.7 and a median of $433849.7 in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments slumped 49.99% — and 2024, when it jumped 34.86%.
- Year by year, Long-Term Investments stood at $593720.9 in 2021, then tumbled by 49.99% to $296892.0 in 2022, then increased by 8.36% to $321706.0 in 2023, then surged by 34.86% to $433849.7 in 2024, then rose by 16.44% to $505194.9 in 2025.
- The last three Long-Term Investments figures came in at $505194.9 (Q4 2025), $433849.7 (Q4 2024), and $321706.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 505,194.89 |
| Jun 30, 2025 | 462,971.51 |
| Dec 31, 2024 | 433,849.73 |
| Jun 30, 2024 | 331,681.37 |
| Dec 31, 2023 | 321,706.03 |
| Jun 30, 2023 | 320,143.77 |
| Dec 31, 2022 | 296,891.98 |
| Jun 30, 2022 | 375,603.95 |
| Dec 31, 2021 | 593,720.92 |
| Jun 30, 2021 | 599,727.18 |
| Dec 31, 2020 | 602,106.37 |
| Dec 31, 2019 | 585,543.58 |
| Dec 31, 2018 | 636,899.21 |